JOURNAL ARTICLE

Blocking GluR2–GAPDH ameliorates experimental autoimmune encephalomyelitis

Abstract

The GluR2 -GAPDH complex represents a novel therapeutic target for the development of medications for MS that work through a different mechanism than existing treatments.

Keywords:
Medicine AMPA receptor Experimental autoimmune encephalomyelitis Multiple sclerosis Encephalomyelitis Glutamate receptor Autoimmunity Immunology Neuroprotection Receptor Pharmacology Immune system Internal medicine

Metrics

21
Cited By
1.16
FWCI (Field Weighted Citation Impact)
29
Refs
0.79
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

RNA Interference and Gene Delivery
Life Sciences →  Biochemistry, Genetics and Molecular Biology →  Molecular Biology
Viral Infections and Immunology Research
Health Sciences →  Medicine →  Cardiology and Cardiovascular Medicine
Immune Response and Inflammation
Life Sciences →  Immunology and Microbiology →  Immunology
© 2026 ScienceGate Book Chapters — All rights reserved.